Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x107px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Ireland and UK or involving organisations from these countries.

Total search results: 2628 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Orchard Therapeutics–SEVERAL: investment, 201808 financing round Series C $150m led by Deerfield Management 2018-08-13
Artios Pharma–AbbVie: investment, 201808 financing round Series B totalling $84m incl existing + co-investor AbbVie Ventures 2018-08-10
Artios Pharma–Andera Partners: investment, 201808 financing round Series B totalling $84m (£65m) incl new + lead investors Andera Partners + LSP 2018-08-10
Artios Pharma–Arix Bioscience: investment, 201808 financing round Series B totalling $84m incl existing + co-investor Arix Bioscience 2018-08-10
Artios Pharma–IP Group: investment, 201808 financing round Series B totalling $84m incl existing + co-investor IP Group 2018-08-10
Artios Pharma–Life Sciences Partners: investment, 201808 financing round Series B totalling $84m incl new + lead investors Andera Partners + LSP 2018-08-10
Artios Pharma–Merck (DE): investment, 201808 financing round Series B totalling $84m incl existing + co-investor M Ventures 2018-08-10
Artios Pharma–Novartis: investment, 201808 financing round Series B totalling $84m incl new + co-investor Novartis Venture Fund 2018-08-10
Artios Pharma–Optimum Strategic Communications: public relations, 201808 service existent by Optimum 2018-08-10
Artios Pharma–Pfizer: investment, 201808 financing round Series B totalling $84m incl new + co-investor Pfizer Ventures 2018-08-10
Artios Pharma–SEVERAL: investment, 201808 financing round Series B $84m (£65m) led by new investors Andera Partners + LSP 2018-08-10
Artios Pharma–SV Health Investors: investment, 201808 financing round Series B totalling $84m incl existing + co-investor SV 2018-08-10
Vernalis–Ligand: investment, 201808– recommended cash takeover offer £32.8m with £0.062/share ANNOUNCED 2018-08-09
United Kingdom (govt)–Bruker Corp: NMR technology, 201808 supply £20m NMR technology to 8 UK universities funded by EPSRC + BBSRC + MRC +NERC 2018-08-06
Univ Birmingham–Bruker Corp: NMR spectrometer, 201808 supply 1GHz NMR spectrometer 2018-08-06
Univ Warwick–Bruker Corp: NMR spectrometer, 201808 supply Avance 1.0 GHz solid-state NMR spectrometer 2018-08-06
Molecular Discovery–Lead Molecular Design: mass spectrometry s/w, 201808 distribution existent of MetaSite + MassMetaSite et al by Molecular Discovery 2018-08-04
Waters–Molecular Discovery: mass spectrometry s/w, 201808– collab product integration MetaSite + MassMetaSite s/w with UNIFI Platform 2018-08-02
Kiadis–Kreos Capital: credit, 201808– debt financing up to €20m in 2 tranches 9% annual interest + end of loan 5% of drawn amount + 41k warrants 2018-08-01
Phico Therapeutics–United Kingdom (govt): grant, 201808 Innovate UK grant £1.4m for developm of manufacturing of SASPject PT3.8 w TCTC + GE Heatlhcare 2018-08-01
Phico Therapeutics–Zyme Communications: public relations, 201808 service existent by Zyme 2018-08-01
ReViral–Andera Partners: investment, 201808 financing round Series B totalling $55m incl existing + co-investor Andera Partners 2018-08-01
ReViral–EMS (BR): investment, 201808 financing round Series B totalling $55m incl existing + co-investor Brace Pharma Capital 2018-08-01
ReViral–New Leaf Venture: investment, 201808 financing round Series B totalling $55m incl new + co-lead investor NLV Partners 2018-08-01
ReViral–Novo Group: investment, 201808 financing round Series B totalling $55m incl new + co-lead investor Novo Ventures 2018-08-01
ReViral–OrbiMed Advisors: investment, 201808 financing round Series B totalling $55m incl existing + co-investor OrbiMed 2018-08-01
ReViral–Perceptive Advisors: investment, 201808 financing round Series B totalling $55m incl new + co-investor Perceptive Advisors 2018-08-01
ReViral–SEVERAL: investment, 201808 financing round Series B $55m co-lead by new investors New Leaf Venture Partners + Novo Ventures 2018-08-01
B&W Tek–Metrohm: investment, 201807 acquisition €na of B&W Tek LLC + several overseas subisidiaries 2018-07-27
Healx–Amadeus Capital: investment, 201807 financing round Series A totalling $10m incl existing + co-investor Amadeus Capital Partners 2018-07-26
Healx–Balderton Capital: investment, 201807 financing round Series A totalling $10m incl led + new investor Balderton Capital 2018-07-26
Healx–PERSON: investment, 201807 financing round Series A totalling $10m incl existing + co-investor Jonathan Milner 2018-07-26
Healx–SEVERAL: investment, 201807 financing round Series A $10m led by new investor Balderton Capital 2018-07-26
Royal Society of Chemistry–ACD/Labs: cheminformatics, 201807– collab renewal ChemSpider to use ACD/Labs Percepta + ACD/Name tools s/w 2018-07-26
Nabriva–SEVERAL: investment, 201807 public offering $50m+$7.5m with 18.2m+2.7m ordinary shares at $2.75/share 2018-07-25
Replimune–SEVERAL: investment, 201807 IPO $100.5m with 6.7m common shares at $15/share 2018-07-24
Zavante Therapeutics–Nabriva: investment, 201807– acquisition upfront 8.2m Nabriva ordinary shares (=19.9% shareholding) + $97.5m milestones 2018-07-24
Endomagnetics–Zyme Communications: public relations, 201807 service existent for Endomag by Zyme 2018-07-23
Replimune–Verge Scientific Communications: public relations, 201807 service existent media relations by Verge 2018-07-19
Replimune–Westwicke Partners: public relations, 201807 service existent IR by Westwicke Partners 2018-07-19
United Kingdom (govt)–Agilent: analytical instruments, 201807 supply existent multi-million-pound framework agreement with UK Home Office 2018-07-19
Axol Bioscience–BioStrata: public relations, 201807 service existent by BioStrata 2018-07-17
Holtzbrinck–Scott Partnership: public relations, 201807– supply service marcom for BioData 2018-07-16
Omnes Capital–Brackendale Consulting: public relations, 201807 service existent by Brackendale Consulting 2018-07-12
Forbion–SEVERAL: investment, 201807 first close €270m of Forbion IV fund 2018-07-11
BioNTech–Consilium: public relations, 201807 service existent international media relations + European IR by CSC 2018-07-10
Summit–CARB-X: grant, 201807– grant $2m + optional $2.5m for antibiotics drug discovery for gonorrhoea using Discuva Platform 2018-07-10
Summit–Consilium: public relations, 201807 service existent by CSC 2018-07-10
Abingworth–Goodwin Procter: legal services, 201807 supply service legal counsel for $315m Abingworth Bioventures VII Fund 2018-07-09
Abingworth–SEVERAL: investment, 201807 final closing of $315m Abingworth Bioventures VII Fund 2018-07-09
Yposkesi–Andrew Lloyd Associates: public relations, 201807 service existent by ALA 2018-07-09
Basilea–Coulter Partners: recruitment services, 201807 supply service placement of Gerrit Hauck as new CTO of Basilea Pharmaceutica Intl Ltd 2018-07-04
Abcam–Instinctif Partners: public relations, 201807 service existent by Instinctif 2018-07-02
Telix–Abzena: biopharmaceuticals, 201807– supply $5.9m strategic manufacturing + bioconjugation agreement 2018-07-02
AMS Biotechnology–Univ Strathclyde: drug screening technology, 201807 collab establishment of joint venture ScreenIn3D in Glasgow 2018-07-01
GSK–MolMed: lentiviral vectors, 201807–202106 collab 3y developm + manufacture of lentiviral vectors by MolMed for GSK oncology programme 2018-07-01
Kymab–1AB Media: public relations, 201806 service existent US media relations by 1AB Media 2018-06-28
Kymab–Consilium: public relations, 201806 service existent UK media relations by CSC 2018-06-28
NodThera–5AM Ventures: investment, 201806 financing round Series A totalling £28m ($40m) co-led by Sofinnova Partners + 5AM Ventures 2018-06-25
NodThera–Consilium: public relations, 201806 service existent by CSC 2018-06-25
NodThera–Epidarex Capital: investment, 201806 financing round Series A totalling £28m ($40m) incl existing co-investor Epidarex Capital 2018-06-25
NodThera–F-Prime: investment, 201806 financing round Series A totalling £28m ($40m) incl co-investor F-Prime Capital Partners 2018-06-25
NodThera–Selvita: investment, 201806 existing investor 2018-06-25
NodThera–SEVERAL: investment, 201806 financing round Series A £28m ($40m) co-led by Sofinnova Partners + 5AM Ventures 2018-06-25
NodThera–Sofinnova: investment, 201806 financing round Series A totalling £28m ($40m) co-led by Sofinnova Partners + 5AM Ventures 2018-06-25
Autolus–JW Communications: public relations, 201806 service existent media relations by JW Communications 2018-06-22
Autolus–SA Noonan Communications: public relations, 201806 service existent IR by SA Noonan 2018-06-22
AdoRx–Charlotte Street Partners: public relations, 201806 service existent by CSP 2018-06-21
AdoRx–Epidarex Capital: investment, 201806 1st financing round totalling $10m from Epidarex Capital + CRT Pioneer Fund 2018-06-21
AdoRx–SEVERAL: investment, 201806 1st financing round $10m from Epidarex Capital + CRT Pioneer Fund 2018-06-21
AdoRx–Sixth Element Capital: investment, 201806 1st financing round totalling $10m from Epidarex Capital + CRT Pioneer Fund 2018-06-21
PhoreMost–o2h Discovery: drug discovery, 201806– collab using o2h’s medicinal chemistry to advance drug discovery projects of PhoreMost 2018-06-21
Labstep–SEVERAL: investment, 201806 financing round £1m from angel investors 2018-06-20
Freeline Therapeutics–JW Communications: public relations, 201806 service existent by JW Communications 2018-06-19
Freeline Therapeutics–SEVERAL: investment, 201806 financing round Series B £88.4m with £85m from Syncona Ltd + £3.4m from UCL TF 2018-06-19
Freeline Therapeutics–Univ College London: investment, 201806 financing round Series B totalling £88.4m incl £3.4m from UCL TF 2018-06-19
Freeline Therapeutics–Wellcome Trust: investment, 201806 financing round Series B totalling £88.4m incl £85m from Syncona Ltd 2018-06-19
Remote Diagnostic Technologies–Philips: investment, 201806 acquisition €na of RDT by Philips 2018-06-13
Kandy Therapeutics–Consilium: public relations, 201806 service existent by CSC 2018-06-07
Roche–Microbiotica: microbiomics, 201806– collab multi-year up to $534m r+d + commerc of markers + targets + treatments for IBD w Genentech 2018-06-06
Roivant–Oxford BioMedica: Parkinson’s gene therapy, 201806– license ww excl to OXB-102 $30m upfront + $812.5m milestones to Axovant Sciences 2018-06-06
Univ Birmingham–Thermo Fisher: mass spectrometer, 201806 supply existent early customer Orbitrap ID-X Tribrid MS system at PCB 2018-06-04
Arix Bioscience–Evotec: drug discovery, 201805–202304 collab partnership LAB591 for early-stage projects out of Fred Hutchinson Cancer Center 2018-05-31
Arix Bioscience–Fred Hutchinson: drug discovery, 201805–202304 collab partnership LAB591 for early-stage projects out of Fred Hutch with Evotec 2018-05-31
Evotec–Fred Hutchinson: drug discovery, 201805–202304 collab partnership LAB591 for early-stage projects out of Fred Hutch with Arix Bioscience 2018-05-31
Univ Tübingen–ERS Genomics: CRISPR technology, 201804– license €na to NMI + NMI TT Pharmaservices to expand custom cell-based research services 2018-05-31
F-Star–Denali Therapeutics: investment, 201805 acquisition of F-Star Gamma Ltd via early exercise of option for asset-centric vehicle 2018-05-30
ThromboGenics–Bicycle Therapeutics: small-molecule drugs, 201805– collab expansion r+d of bicycle peptides for eye diseases 2018-05-25
AstraZeneca–Bicycle Therapeutics: small-molecule drugs, 201805– collab expansion r+d of bicycle peptides for respiratory + cardio-metabolic diseases 2018-05-24
Bicycle Therapeutics–Argot Partners: public relations, 201805 service existent IR by Argot Partners 2018-05-24
Stable Arm (MY)–Microsaic: mass spectrometer, 201805– distribution of Microsaic’s 4500 MiD MS detector in Malaysia 2018-05-24
Orbit Discovery–Borealis Ventures: investment, 201805 financing round Series A totalling £6.9m incl new + co-investor Borealis Ventures 2018-05-23
Orbit Discovery–Perivoli Trust: investment, 201805 financing round Series A totalling £6.9m incl new + co-investor Perivoli Innovations 2018-05-23
Orbit Discovery–RT Ventures: investment, 201805 financing round Series A totalling £6.9m incl new + co-investor RT Ventures 2018-05-23
Orbit Discovery–SEVERAL: investment, 201805 financing round Series A £6.9m led by Oxford Sciences Innovation 2018-05-23
Orbit Discovery–Univ Oxford: investment, 201805 financing round Series A totalling £6.9m incl existing + lead investor Oxford Sciences Innovation 2018-05-23
Bionure–Alta Partners: investment, 201805 financing round Series A totalling €4m incl lead investor Alta Life Sciences 2018-05-16
Bionure–SEVERAL: investment, 201805 financing round Series A €4m led by Alta Life Sciences 2018-05-16
Otsuka–Thermo Fisher: electron microscope, 201805 supply of Glacios Cryo-TEM to Astex Pharmaceuticals Ltd 2018-05-16
Univ Cambridge–Thermo Fisher: electron microscope, 201805 supply existent Krios Cryo-TEM at Cambridge Univ 2018-05-16
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page



Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x107px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BioPharm America 2018 Boston Partnering 560x80px

» top